Study of relationship between volume of distribution and body weight application to amikacin

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 39, Issue 2, 2014, Pages 87-91

  Rughoo, L ^a   Bourguignon, L ^a,b   Maire, P ^a,b   Ducher, M ^b  

^a UNIVERSITÉ DE LYON   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

Amikacin; Body weight; NPAG; Population pharmacokinetic; Z method

Indexed keywords

AMIKACIN;

ADULT; AGED; ALGORITHM; ARTICLE; BODY WEIGHT; COMPARTMENT MODEL; CONTROLLED STUDY; CORRELATION COEFFICIENT; CREATININE CLEARANCE; DISTRIBUTION VOLUME; FEMALE; HUMAN; MALE; NONLINEAR SYSTEM; PARAMETRIC TEST; RETROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMIKACIN; ANTI-BACTERIAL AGENTS; BODY WEIGHT; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84902375597     PISSN: 03787966     EISSN: 21070180     Source Type: Journal    
DOI: 10.1007/s13318-013-0160-y     Document Type: Article

References (16)

1. Bauer LA, Edwards WA, Dellinger EP et al (1983a) Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients. Eur J Clin Pharmacol 24(5):643-647 (Pubitemid 13092243)
2. Bauer LA, Blouin RA, Griffen WO Jr et al (1983b) Amikacin pharmackinetics in morbidly obese patients. Eur J Clin Pharmacol 24:643-647
3. Bleyzac N, Allard-Latour B, Laffont A et al (2000) Diurnal changes in the pharmacokinetic behavior of amikacin. Ther Drug Monit 22(3):307-312 (Pubitemid 30346447)
4. Bourguignon L, Goutelle S, Gérard C et al (2009) Pharmacocinétique de l'amikacine chez l'adulte : une hété rogénéité qui remet en cause le calcul de la dose basé sur le poids. Thérapie 64(1):47-53
5. Bressolle F, Gouby A, Martinez JM et al (1996) Population pharmacokinetics of amikacin in critically ill patients. AAC 40(7):1682-1689 (Pubitemid 26227357)
6. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41
7. Ducher M, Cerutti C, Gustin MP et al (1994) Statistical relationships between systolic blood pressure and heart rate and their functional significance in conscious rats. Med Biol Eng Comput 32:649-655
8. Ducher M, Cerutti C, Gustin MP et al (1999) Noninvasive exploration of cardiac autonomic neuropathy. Four reliable methods for diabetes? Diabetes Care 22:383-393
9. Ducher M, Maire P, Cerutti C et al (2001) Renal elimination of amikacin and the aging process. Clin Pharmacokinet 40:947-953 (Pubitemid 34066689)
10. Ducher M, Fauvel JP, Maurin M et al (2003) Sodium intake and blood pressure in healthy individuals. J Hypertens 21:289-294 (Pubitemid 36269699)
11. Forbes GB, Welle SL (1983) Lean body mass in obesity. Int J Obes 7:99-107 (Pubitemid 13097059)
12. Leary R, Jelliffe R, Schumitzky A, et al (2001) An adaptive grid nonparametric approach to pharmacokinetic and dynamic (PK/PD) population models. In: Proceedings of the 14th IEEE Symposium on Computer Based Medical Systems, July 26-27; Bethesda (MD), pp 389-94
13. Mallet A, Mentre F, Gilles J et al (1988) Handling covariates in population pharmacokinetics with an application to gentamicin. Biomed Meas Infor Contr 2(3):138-146
14. Sheiner L, Beal S (1981) Some suggestions for measuring predictive performances. J Pharmacokinet Biopharm 9:503-512
15. Sheiner L, Rosenberg B, Marathe VV (1977) Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biop 5(5):445-479 (Pubitemid 8224518)
16. Traynor AM, Nafziger AN, Bertino JS Jr (1995) Aminoglycoside dosing weight correction factors for patients of various body sizes. AAC 39(2):545-548